This study was designed to investigate the role of calmodulin in adrencrgic neurotransmission of resistance vessels. The effects of various calmodulin antagonists (trifluoperazine, W-7, calmidazolium, chlorpromazine, fluphenazine) on the vascular responsiveness and norepinephrine overflow from adrenergic nerve endings were examined in perfused rat mesenteric vasculature preparations. Pressor responses to electrical nerve stimulation or exogenous norepinephrine were inhibited dose-dependently by each calmodulin antagonist.
IT is widely accepted that calcium (Ca++) plays a key role in both nor- was performed during the stable period of each preparation. Fig.1 shows the effects of trifluoperazine on the pressor responses to nerve stimulation.
The basal perfusion pressure was not affected by trifluoperazine in the concentrations used in this experiment.
Trifluoperazine inhibited the electrically-induced pressor responses dose-dependently. The pressor responses recovered almost to the control level when trifluoperazine was washed out from the perfusion medium (Fig.1) . The pressor responses to exogenous norepinephrine were also inhibited by trifluoperazine, but the attenuation was less than that observed for electri- 
DISCUSSION
Calcium has a major role in neurotransmission in the cardiovascular system, especially in neurotransmitter release and in vascular smooth muscle contractions. The importance of Ca++ in neurotransmitter release has been demonstrated by many authors.1)-3) The term "stimulus-secretion coupling" suggests that the Ca++-influx across the cell membrane is an inevitable concomitant of the stimulus, and is necessary for transmitter release. Our previous reports also showed that Ca++-antagonists, such as verapamil and diltiazem, affected both pre-and post-synaptic sites of resistance vessels and caused a decrease in electrically-stimulated norepinephrine release from the adrenergic nerve endings distributed in rat mesenteric arteries, in addition to direct effects on vascular smooth muscle.11), 12) It is generally accepted that calmodulin is an intracellular Ca++-binding protein that modulates the effects of Ca++ on several important enzyme systems. The present study with calmodulin antagonists13),14) is an attempt to evaluate the contributions of endogenous calmodulin to both norepinephrine release from adrenergic nerve endings and vascular muscle contractions. In the rat mesenteric vasculature, different classes of calmodulin antagonists inhibited norepinephrine release and vascular responsiveness to endogenous and exogenous norepinephrine in a dose-dependent manner.
It has been reported that antipsychotic drugs such as trifluoperazine, fluphenazine and chlorpromazine bind to calmodulin. However, Norman et al reported that correlation between the activity of these drugs as calmodulin antagonists and as antipsychotics is poor, suggesting the involvement of other non-specific actions of the drugs.15) In contrast, W-7 and calmidazolium have potent inhibitory actions on phosphodiesterase activity. In particular, W-7 may penetrate the cell membranes quickly to enter the cytoplasm,16) and seems to be the most specific antagonist for calmodulin.13),14),17) Asano et al reported that W-7 and other calmodulin antagonists reduced the contractile responses of aortic strips to norepinephrine, serotonin, histamine, prostaglandin F2a, angiotensin II or KCl.17) On the other hand, hormonal release is analogous with the electromechanical coupling that is characteristic of the muscle contraction.3) Kenigsberg et al reported that trifluoperazine inhibited the acetylcholine-or KCl-induced release of norepinephrine from cultured adrenal chromaffin cells.18) However, few studies have investigated the effects of calmodulin antagonists on norepinephrine release from sympathetic nerve endings in the vascular beds. In this study, direct measurements suggested that W-7 and other calmodulin antagonists could suppress electrically-stimulated norepinephrine release from the nerve terminals in isolated mesenteric vasculature preparations.
Therefore, calmodulin may be involved in the process of adrenergic transmission in vascular beds. There are several possible mechanisms of actions of calmodulin in neurotransmitter release. 19) In vascular smooth muscle cells, the activation of myosin by actin is mediated by calmodulin, and the phosphorylation of myosin light chain kinase is a calmodulin-dependent process.4)-6) Also in pre-synaptic neurons, calmodulin may mediate the effects of calcium on synaptic protein phosphorylation.7),20),21) DeLorenzo et al also suggested a role of calmodulin in vesicle (containing neurotransmitters)-cytoplasmic membrane interactions.7) Furthermore, calmodulin may regulate endogenous tubulin kinase activity in pre-synaptic nerve terminals,22) although the precise role of calmodulin in regulating many of the aspects of synaptic function remains to be identified.
